Table 2 HBM-related ART perceptions of participants diagnosed before and after implementing the new ART strategy
From: HIV diagnosis period influences ART initiation: findings from a prospective cohort study in China
| Â | All n (%) | Diagnosed before implementing the new strategy n (%) | Diagnosed after implementing the new strategy n (%) | P |
|---|---|---|---|---|
Perceived severitya (agree/extremely agree) | ||||
 Not starting ART may lead to poor treatment effect | 361 (87.8) | 117 (78.0) | 244 (93.5) | < 0.001 |
 Not starting ART may increase the possibility of treatment failure | 344 (83.7) | 113 (75.3) | 231 (88.5) | 0.001 |
 Not starting ART may accelerate progress of AIDS | 370 (90.0) | 123 (82.0) | 247 (94.6) | < 0.001 |
 Not starting ART may lead to drug resistance | 287 (69.8) | 87 (58.0) | 200 (76.6) | < 0.001 |
Perceived susceptibility (agree/extremely agree) | ||||
 Not starting ART may increase the possibility of transmitting HIV to my sexual partner | 367 (89.3) | 129 (86.0) | 238 (91.2) | 0.102 |
Perceived benefitsb (agree/extremely agree) | ||||
 Starting ART may increase my CD4 cell counts effectively | 372 (90.5) | 133 (88.7) | 239 (91.6) | 0.333 |
 Starting ART may promote the reconstitution of my immune system effectively | 364 (88.6) | 130 (86.7) | 234 (89.7) | 0.359 |
 Starting ART may reduce the possibility of drug resistance | 281 (68.4) | 95 (63.3) | 186 (71.3) | 0.096 |
 Starting ART may reduce the possibility of drug complications | 378 (92.0) | 133 (88.7) | 245 (93.9) | 0.062 |
 Starting ART may prolong life and reduce the possibility of death | 366 (89.1) | 131 (87.3) | 235 (90.0) | 0.398 |
 Starting ART may reduce the possibility of transmitting HIV to others | 342 (83.2) | 121 (80.7) | 221 (84.7) | 0.295 |
Perceived barriersc (agree/extremely agree) | ||||
 Early ART may lead to early side effects | 162 (39.4) | 61 (40.7) | 101 (38.7) | 0.694 |
 Early ART may lead to early drug resistance | 107 (26.0) | 38 (25.3) | 69 (26.4) | 0.806 |
 Early ART leads to early uptake of a lifelong medication burden | 235 (57.2) | 93 (62.0) | 142 (54.4) | 0.134 |
 Early ART may interfere with life | 142 (34.5) | 61 (40.7) | 81 (31.0) | 0.053 |
 Early ART may cause an economic burden | 128 (31.1) | 55 (36.7) | 73 (28.0) | 0.067 |
 Early ART may increase the possibility of disclosure of one’s infection status | 194 (47.2) | 84 (56.0) | 110 (42.1) | 0.007 |
Self-efficacyd (some/very) | ||||
 How confident are you that you will start ART now? | 273 (66.4) | 90 (60.0) | 183 (70.1) | 0.037 |
 How confident are you that you will prepare to start ART? | 331 (80.5) | 102 (71.3) | 124 (85.8) | < 0.001 |
 How confident are you that you will schedule your personal and work life in order to start ART? | 312 (75.9) | 100 (66.7) | 212 (81.2) | 0.001 |
 How confident are you to participate in antiviral treatment in the next 6 months? | 330 (80.3) | 101 (67.3) | 229 (87.7) | < 0.001 |
 How confident are you to participate in antiviral therapy in the coming year? | 341 (83.0) | 107 (71.3) | 234 (89.7) | < 0.001 |